 |
SINGAPORE, May 23, 2025 /PRNewswire/ -- Sennheiser has proudly participated in the 11th Asia-Pacific Spectrum Management Conference as the Official Audio Partner. Held in Bangkok, Thailand from 13 – 14 March 2025, this event brought together global policymakers, regulators, and industry leaders to address the most pressing spectrum issues shaping the future of wireless communication and connectivity in the Asia-Pacific region. This event is part of The Global Spectrum Series, the world's largest collection of regional spectrum policy conferences.
Sennheiser has been an active participant and sponsor of the Asia-Pacific Spectrum Management Conference since 2013, promoting the inclusion of PMSE (Programme Making and Special Events) in spectrum policy dialogues and, more specifically, highlighting the inherent need for allocation of frequency bands to operate wireless microphone systems in the region.
Sennheiser was represented at this year's conference by Vaughan John, Spectrum Policy and Standards Manager, who contributed to an expert panel discussion, shedding light on the evolving influences of 5G on PMSE. John also shared insights on the "5G Story in Audio PMSE," highlighting how the new DECT NR+ standard will finally make the promises of 5G towards PMSE come true, and elaborating on the work of the MERCI project.
"As new spectrum policies emerge, it is critical for PMSE to have a voice in the conversation," said John. "Sennheiser is committed to collaborating with regulators and stakeholders to ensure the needs of the audio industry are included in discussion when developing spectrum policy—especially in regions as diverse and dynamic as Asia-Pacific."
"DECT NR+ will fulfil the promises that 5G made towards PMSE users," says Vaughan John, Spectrum Policy and Standards Manager at Sennheiser
Sennheiser's involvement in the conference highlights its long-standing engagement with spectrum policy and its ongoing mission to protect and promote spectrum access for wireless microphones and audio PMSE users.
The Asia-Pacific Spectrum Management Conference, organized by Forum Global in partnership with the Asia-Pacific Telecommunity (APT) and the International Telecommunication Union (ITU), featured sessions focused on spectrum harmonization, mid-band deployment, 6G innovation, and regulatory frameworks for satellite and direct-to-device connectivity.
Sennheiser remains dedicated to supporting the global audio community through thought leadership, industry partnerships, and technology solutions that meet the demands of today's wireless landscape.
About the Sennheiser brand
We live and breathe audio. We are driven by the passion to create audio solutions that make a difference. Building the future of audio and bringing remarkable sound experiences to our customers – this is what the Sennheiser brand has represented for more than 75 years. While professional audio solutions such as microphones, meeting solutions, streaming technologies and monitoring systems are part of the business of Sennheiser electronic GmbH & Co. KG, the business with consumer devices such as headphones, soundbars and speech-enhanced hearables is operated by Sonova Holding AG under the license of Sennheiser.
www.sennheiser.com
www.sennheiser-hearing.com
SINGAPORE, May 23, 2025 /PRNewswire/ -- Sennheiser has proudly participated in the 11th Asia-Pacific Spectrum Management Conference as the Official Audio Partner. Held in Bangkok, Thailand from 13 – 14 March 2025, this event brought together global policymakers, regulators, and industry leaders to address the most pressing spectrum issues shaping the future of wireless communication and connectivity in the Asia-Pacific region. This event is part of The Global Spectrum Series, the world's largest collection of regional spectrum policy conferences.
Sennheiser has been an active participant and sponsor of the Asia-Pacific Spectrum Management Conference since 2013, promoting the inclusion of PMSE (Programme Making and Special Events) in spectrum policy dialogues and, more specifically, highlighting the inherent need for allocation of frequency bands to operate wireless microphone systems in the region.
Sennheiser was represented at this year's conference by Vaughan John, Spectrum Policy and Standards Manager, who contributed to an expert panel discussion, shedding light on the evolving influences of 5G on PMSE. John also shared insights on the "5G Story in Audio PMSE," highlighting how the new DECT NR+ standard will finally make the promises of 5G towards PMSE come true, and elaborating on the work of the MERCI project.
"As new spectrum policies emerge, it is critical for PMSE to have a voice in the conversation," said John. "Sennheiser is committed to collaborating with regulators and stakeholders to ensure the needs of the audio industry are included in discussion when developing spectrum policy—especially in regions as diverse and dynamic as Asia-Pacific."
"DECT NR+ will fulfil the promises that 5G made towards PMSE users," says Vaughan John, Spectrum Policy and Standards Manager at Sennheiser
Sennheiser's involvement in the conference highlights its long-standing engagement with spectrum policy and its ongoing mission to protect and promote spectrum access for wireless microphones and audio PMSE users.
The Asia-Pacific Spectrum Management Conference, organized by Forum Global in partnership with the Asia-Pacific Telecommunity (APT) and the International Telecommunication Union (ITU), featured sessions focused on spectrum harmonization, mid-band deployment, 6G innovation, and regulatory frameworks for satellite and direct-to-device connectivity.
Sennheiser remains dedicated to supporting the global audio community through thought leadership, industry partnerships, and technology solutions that meet the demands of today's wireless landscape.
About the Sennheiser brand
We live and breathe audio. We are driven by the passion to create audio solutions that make a difference. Building the future of audio and bringing remarkable sound experiences to our customers – this is what the Sennheiser brand has represented for more than 75 years. While professional audio solutions such as microphones, meeting solutions, streaming technologies and monitoring systems are part of the business of Sennheiser electronic GmbH & Co. KG, the business with consumer devices such as headphones, soundbars and speech-enhanced hearables is operated by Sonova Holding AG under the license of Sennheiser.
www.sennheiser.com
www.sennheiser-hearing.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Sennheiser Strengthens Role in Spectrum Dialogue as Official Audio Partner at the 11th Asia-Pacific Spectrum Management Conference
Sennheiser Strengthens Role in Spectrum Dialogue as Official Audio Partner at the 11th Asia-Pacific Spectrum Management Conference
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
